RxDoctor Payments Data

Daniela Maxim

Family · Troy, MINPI 1962892307

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $76,416 of the $111,560 with a category attached, or 68.5%. 30 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 58.1% of the total. Reporting peaked in 2024 at $29,839 and has fallen 54.5% since, to $13,565 in 2025. Among family clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$111,560in general payments, 2019–2025

Across 819 payments — averaging $136.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$65K
  • Sanofi$19K
  • Galderma Laboratories, L.p.$14K
  • Johnson & Johnson$3K
  • LEO Pharma Inc.$2K
  • Sun Pharmaceutical Industries Inc.$2K
  • plus $8K from 24 others

What the payments were for

  • Consulting fees$1,5601%
  • Speaking & faculty fees$76,41668%
  • Travel & lodging$12,43311%
  • Food & beverage$20,09518%
  • Education$1,0561%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$111,560 in reported general payments places this provider in the 95th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Medicare billing

Part B allowed, 2024
$317,188
Medicare patients
379
Services billed
4,077

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab27$98,850
Clobetasol Propionate119$4,436
Metronidazole48$3,499
Tacrolimus19$2,260
Doxycycline Hyclate66$1,847
Ketoconazole104$1,720
Triamcinolone Acetonide154$1,660
Mometasone Furoate52$1,090
Azelaic Acid11$1,071
Mupirocin143$945
Clindamycin Phosphate29$921
Betamethasone Dipropionate14$513
Fluocinonide22$429
Econazole Nitrate17$406
ValacyclovirValacyclovir Hcl19$405

Paid to pharmacies, not to this prescriber.

Other family in Troy

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →